Oruka Therapeutics, Inc. ORKA Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Oruka Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s quick ratio?
- Oruka Therapeutics, Inc. (ORKA) reported quick ratio of 23.8× in Q1 2026.
- How has Oruka Therapeutics, Inc.'s quick ratio changed year-over-year?
- Oruka Therapeutics, Inc.'s quick ratio decreased by 20.9% year-over-year, from 30× to 23.8×.
- What is the long-term trend for Oruka Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s quick ratio has grown at a 9.4% compound annual growth rate (CAGR), from 14.3× to 22.4×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.